• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthcare?
 

Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthcare?

on

  • 3,257 views

Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with ...

Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.

Statistics

Views

Total Views
3,257
Views on SlideShare
3,249
Embed Views
8

Actions

Likes
2
Downloads
197
Comments
0

3 Embeds 8

http://www.linkedin.com 6
http://www.slideshare.net 1
http://paper.li 1

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Social media guru Clay shirkey has written a great deal about this Has also commented on implications for healthcare and the role of patients and consumers in making healthcare decisions.
  • Social media guru Clay shirkey has written a great deal about this Has also commented on implications for healthcare and the role of patients and consumers in making healthcare decisions.
  • Alliance of 32 hospital-based patient groups
  • Referring to new role for government and private (pharma) healthcare sector
  • Being copied and adapted globally
  • Data sold to pharmas, huge market research potential Biz model on which PLM is based
  • -
  • Ray Kerin, Head of PR Pfizer, 2009, interview with industry commentator John Mack Thought lomg and hard whether to include this topic Interest of openness and transparency thought would be best
  • - Key question: How do we build trust again? - Industry must get back in to the convesation But not by simply sending out the same messahe via SM - Must really engage, open up, talk Other indsuries do, but have an easier time
  • - One crucial area where trust is crucial = R&D
  • Know Marc very well Not marketeer, scientist, medic, or lawyer Excellent communicator - Degree in English -Industry needs more communicators that stakeholders can trust
  • 4500 followers
  • Don‘t yet know what openness will ultimately look like - All working on it - Can only be a good thing

Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthcare? Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthcare? Presentation Transcript

  • Collaborative Digital Pharma Marketing A Role Model for Asia Pacific Healthcare? Len Starnes Head of Digital Marketing & Sales General Medicine From Drugs to Brands Singapore 10 March 2011 Len Starnes Bayer Healthcare Pharma
  • Pharma is reinventing itself
  • ‘ We are living in the middle of the largest increase in expressive capability in the history of the human race’ Clay Shirkey, Here Comes Everybody, 2008
  • Collaboration Process where two or more people or organizations work together to realize shared goals Wikipedia
  • The power of digital collaboration
  • Social networking Public relations Consumers & patients Non-traditional HC partners Physicians High-impact zones R&D & Clinical E 2.0
  • Collaborative digital marketing is not for the faint-hearted Warning
  • Physicians
  • Physicians’ social networks Ubiquitous Transformational
  • Transforming the exchange of medical information Pharmaceutical industry Peer-to-peer dialogue Medical profession Collaborative environment
  • Next 5 years Highly e-savvy physicians Routine use of SNs by majority of physicians More physicians willing to engage with pharma on SNs More physicians expecting e-self service from pharma Fewer physicians willing to see sales reps Predominance of multi-channel engagement models
  • 2010 2009 2008 2007 Sustained growth Today > 70 networks > 3m members Membership of physicians’ social networks 1m 2m 3m 2011
  • 2 million members Asia Pacific 1 million members USA & Europe Asia Pacific region dominates
  • Global network exclusively for cardiologists By invitation only Merges NEJM content with community discussion > 3000 members
  • 180k members Pan-European Alliance 2011 Connecting networks in France Italy Germany Spain UK
  • 115,000 members each
  • Manhattan Research, Taking the Pulse Asia v10, 2010 % physician respondents India and China lead on use Physicians’ social networks
  • World’s largest healthcare professionals’ network 1,700,000 members China dxy.cn
  • haoyisheng.com Visited by 79% of physicians using internet for professional reasons
  • m3.com, Japan Authenticated users 177,000 members Visited by 93% of physicians using internet for professional reasons
  • MediGate S Korea Authenticated users 67,000 members Visited by 72% of physicians using internet for professional reasons
  • Australia’s 1st true doctors’ social network Launched September 2010 > 5000 members* Multiple pharma collaboration options * Status 1.3.11 www.e-healthspace.com.au
  • Pharma’s partnering options Observation Treatment trends, unmet needs Engagement Peer-to-peer dialogue Building hybrid models Community, content & services Research Surveys, opinion
  • Build deeper relationships Open peer-to-peer dialogue Long-term opportunities Develop trusted speciality fora Integrate community & resources Reduce reliance on sales forces Increase reach and SOS
  • 39% prefer Unique opportunities to develop authenticated networks 61% indifferent + prefer no login 65% prefer 35 % indifferent + prefer no login Manhattan Research, Taking the Pulse Asia v10, 2010
  • Patients
  • ‘ Let patients help. We are the ultimate motivated stakeholders ’ ePatient Dave US HIT Policy Committee 25 April 2010
  • Palpably visible
  • ‘ If you have not read this white paper you do not understand the future of medicine’ John Sharp Cleveland Clinic
  • Pharma is discovering the benefits of collaborating with eP atients
  • Mellanie True Hills Former atrial fibrillation sufferer 2,200 Twitter followers
  • Linda Lan-yu Sun President Taiwan Breast Cancer Alliance (TBCA) Empowering patients to ‘talk to doctors as equals’
  • http://www.pharmachinaonline.com/Archives/index_1_news.asp?id=435&sortid=28 ‘… patient education (in China)…needs to shift from simply the provision of information to including motivating and transforming a patient’s mindset to assume a proactive role in his or her own health management’ Learning from Taiwan
  • Patients are… sharing quantitative personal health data
  • The data-driven community Patients share structured information about their disease to help themselves and others Quantifiable, measurable, actionable
  • Insights on drug usage in the real world MS treatment: Copaxone 3050 patient community 1073 patient evaluations Status: 14.2.11
  • ‘ In future the less private you are, the longer you’ll live’ Jamie Heywood Co-founder & Chairman PatientsLikeMe
  • Partnerships to capture real-world experiences ‘… may help UCB better understand how patients live with epilepsy and help advance epilepsy care’ Peter Verdu, VP Clinical Research, UCB, 2009
  • Demonstrable high-level vision ‘… will shape the way we do our work, and ultimately help improve transplant patient outcomes now and in the future.’ Joe Jiminez Novartis CEO, 2010
  • What relationship with ePatients should pharma have? What relationship with pharma do ePatients want?
  • PR Image: eDrug Research.com
  • Mistrust between industry and consumers Broken trust between industry and the medical profession Ethos of the industry is constantly called into question
  • Trust is crucial for survival ‘ We need to foster trust between pharma and academic and scientific communities so that we can work together to create the innovative breakthroughs that will fulfil unmet needs and benefit patients everywhere’ Paul Stoffels Head of Global R&D, Johnson & Johnson
  • JnJ is showing how to build trust again
  • Marc Monseau is the human face of JnJ on the internet… … and a social media evangelist
  • Empowered to get JnJ back into ‘ The Conversation’ ‘ Everyone else is talking about our company, so why can’t we?’
  • Empowered to engage in ‘ what’s happening now’ conversations
  • Empowered to engage the blogging health community
  • Empowered to talk frankly about JnJ’s social media journey ‘ Being open, responsive and timely’
  • Pharma will become more
    • www.linkedin.com/in/lenstarnes www.twitter.com/lenstarnes www.slideshare.net/lenstarnes [email_address]
    • Opinions expressed in this presentation are entirely those
    • of the author and do not necessarily reflect those of his
    • employer
    Len Starnes